Article

OptiMedica unveils new photocoagulator at WOC

OptiMedica Corp. announced the debut of its new photocoagulator (PASCAL Slim Line) here at the World Ophthalmology Congress. The system provides physicians and their patients with the significant benefits of pattern-scanning in a new, compact design.

OptiMedica Corp. announced the debut of its new photocoagulator (PASCAL Slim Line) here at the World Ophthalmology Congress.The system provides physicians and their patients with the significant benefits of pattern-scanning in a new, compactdesign.

Representing a leap forward from single-spot green laser photocoagulation, the company's proprietary, semi-automated patterngeneration allows for the rapid delivery of 532 nm laser pulses in a predetermined sequence. Indicated for a variety ofretinal diseases-including diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusivedisease-the technique enables physicians to improve their control of the precision, safety, and efficiency of thephotocoagulation procedure, while optimizing patient comfort and convenience, according to OptiMedica.

"The launch of the [photocoagulator] represents OptiMedica's unwavering commitment to meeting customer needs," said Mark J.Forchette, president and chief executive officer of OptiMedica. "We are thrilled to report that early users have alreadygiven us rave reviews for [its] performance and sleek design, which together are aimed at addressing the unique clinical andeconomic challenges of the office-based practice."

The new photocoagulator is currently available in the United States and Japan and will be rolled out worldwide over thefourth quarter of 2008.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.